Loading...

VSEE VSEE HEALTH INC Capital Structure Changes 8-K Filing

VS H

VS

VSEE HEALTH INC

(VSEE)

2025 8-K

Annual Meeting Postponed

New Stock Series

Stockholders' Equity Update

Nasdaq Compliance Update

Fundraising Agreement

Convertible Note Agreement

Equity Line Agreement

Warrant Exchange Agreement

Annual Meeting Notice

Debt Amendment Details

Financing Agreement

Management Changes

Financing Agreement

Nasdaq Compliance Notice

Financial Statement Restate...

Nasdaq Delisting Notice

Loan Defaults (Secured, Uns...

Notice of Delisting

Capital Changes

Contract Renewal

Contract Announcement

Contract Awards

Contract Awards

Partnership Announcement

Strategic Partnership

Partnership Announcement

Telehealth Expansion

Financial Results

Partnership Announcement

Obesity Program Launch

Telehealth Initiative

CEO Speaking Engagements

Financial Results

Nasdaq Compliance Notice

Partnership Announcement

Partnership Announcement

Board Appointments

Agreement and Name Change

Special Meeting of Stockhol...

Extension of Business Combi...

Agreement and Note Extensions

Agreement and Loan Conversion

Extension of Business Combi...

Business Combination Agreement

Entry into Material Definit...

Listing Transfer Approval

Amendment to Certificate of...

Extension of Business Combi...

Extension of Time for Busin...

Securities Purchase Agreeme...

Amendment to Securities Pur...

Extension of Business Combi...

Backstop Agreement

External Links:

VSee Health, Inc. designated 2,000 shares of Series B Convertible Preferred Stock at $1,000 each effective December 5, 2025, allowing conversion to common stock at a price of $0.65 per share with specific rights and limitations.

AI Assistant

VSEE HEALTH INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.